title: Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis.
abstract: Myeloid-derived suppressor cells (MDSCs) are significantly increased in cancer patients and tumor bearing-animals. MDSCs infiltrate into tumors and promote tumor invasion and metastasis. To identify the mediator responsible for the prometastatic property of MDSCs, we used proteomics. We found neutrophilic granule protein (NGP) was decreased >2-fold in MDSCs from metastatic 4T1 tumor-bearing mice compared to nonmetastatic 67NR controls. NGP mRNA levels were decreased in bone marrow and in tumor-infiltrating MDSCs by 45 and 66%, respectively, in 4T1 tumor-bearing mice compared to 67NR controls. Interestingly, 4T1-conditioned medium reduced myeloid cell NGP expression by ∼ 40%, suggesting that a secreted factor mediates gene reduction. Sequence analysis shows a putative cystatin domain in NGP, and biochemical analysis confirms NGP a novel cathepsin inhibitor. It inhibited cathepsin B activity by nearly 40% in vitro. NGP expression in 4T1 tumor cells suppressed cell invasion, delayed primary tumor growth, and greatly reduced lung metastasis in vivo. A 2.8-fold reduction of cathepsin activity was found in tumors expressing NGP compared to controls. NGP significantly reduced tumor angiogenesis to 12.6 from 19.6 and lymphangiogenesis to 4.6 from 9.1 vessels/field. Necrosis was detectable only in NGP-expressing tumors, and the number of apoptotic cells increased to 22.4 from 8.3 in controls. Taken together, this study identifies a negative regulator of tumor metastasis in MDSCs, NGP, which is down-regulated in metastatic conditions. The finding suggests that malignant tumors promote invasion/metastasis not only through up-regulation of proteases but also down-regulation of protease inhibitors.
authors.affiliation: Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
authors.forename: Angela M
authors.initials: AM
authors.lastname: Boutté
authors.forename: David B
authors.initials: DB
authors.lastname: Friedman
authors.forename: Matthew
authors.initials: M
authors.lastname: Bogyo
authors.forename: Yongfen
authors.initials: Y
authors.lastname: Min
authors.forename: Li
authors.initials: L
authors.lastname: Yang
authors.forename: P Charles
authors.initials: PC
authors.lastname: Lin
mesh_terms: D000818:Animals; D002401:Cathepsin B / Q000235:genetics / Q000378:metabolism; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D015891:Cystatins / Q000235:genetics / Q000502:physiology*; D005260:Female; D008175:Lung Neoplasms / Q000517:prevention & control / Q000556:secondary; D015674:Mammary Neoplasms, Animal / Q000098:blood supply / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D008807:Mice, Inbred BALB C; D022423:Myeloid Cells / Q000502:physiology*; D009361:Neoplasm Invasiveness / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control; D009362:Neoplasm Metastasis / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D009389:Neovascularization, Pathologic; D011480:Protease Inhibitors / Q000378:metabolism; D040901:Proteomics
chemical_list: D015891:Cystatins; D011480:Protease Inhibitors; D002401:Cathepsin B; C533915:Ctsb protein, mouse